Sun Pharma
Hanwant Singh is an experienced professional in the pharmaceutical industry, currently serving as the Managing Director at both Ranbaxy Nigeria Ltd, a Sun Pharma Company, and SUN PHARMA since April 2015, overseeing operations and leading initiatives in Nigeria. Having joined Ranbaxy in February 2003, Hanwant held the position of Controller Sales & Marketing, managing five business units within the Ethical and OTC divisions as well as leading a large team in Nigeria. Prior to this, Hanwant worked as a Country Representative for Mega Healthcare Ltd in Bangkok, focusing on sales, marketing, planning, and business development. Hanwant holds an MBA in Leadership & Sustainability from the University of Central England and a certificate from the Indian School of Business in Management.
This person is not in any teams
This person is not in any offices
Sun Pharma
21 followers
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 2,000 scientists and R&D investments of over 7-8% of annual revenues. See our community guideline: bit.ly/3DsQxdK